Literature DB >> 8552637

An inhibitor of p34cdc2/cyclin B that regulates the G2/M transition in Xenopus extracts.

T H Lee1, M W Kirschner.   

Abstract

The activity of maturation-promoting factor (MPF), a protein kinase complex composed of p34cdc2 and cyclin B, is undetectable during interphase but rises abruptly at the G2/M transition to induce mitosis. After the synthesis of cyclin B, the suppression of MPF activity before mitosis has been attributed to the phosphorylation of p34cdc2 on sites (threonine-14 and tyrosine-15) that inhibit its catalytic activity. We previously showed that the activity of the mitotic p34cdc2/cyclin B complex is rapidly suppressed when added to interphase Xenopus extracts that lack endogenous cyclin B. Here we show that a mutant of p34cdc2 that cannot be inhibited by phosphorylation (threonine-14-->alanine, tyrosine-15-->phenylalanine) is also susceptible to inactivation, demonstrating that inhibitory mechanisms independent of threonine-14 and tyrosine-15 phosphorylation must exist. We have partially characterized this inhibitory pathway as one involving a reversible binding inhibitor of p34cdc2/cyclin B that is tightly associated with cell membranes. Kinetic analysis suggests that this inhibitor, in conjunction with the kinases that mediate the inhibitory phosphorylations on p34cdc2, maintains the interphase state in Xenopus; it may play an important role in the exact timing of the G2/M transition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8552637      PMCID: PMC40236          DOI: 10.1073/pnas.93.1.352

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

Review 1.  The cdc25 M-phase inducer: an unconventional protein phosphatase.

Authors:  J B Millar; P Russell
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

2.  Regulation of the cdc25 protein during the cell cycle in Xenopus extracts.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

3.  The cdc25 protein contains an intrinsic phosphatase activity.

Authors:  W G Dunphy; A Kumagai
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

4.  Negative regulation of the wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer.

Authors:  T R Coleman; Z Tang; W G Dunphy
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog.

Authors:  P Russell; P Nurse
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

6.  Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.

Authors:  T Evans; E T Rosenthal; J Youngblom; D Distel; T Hunt
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

7.  Site-specific mutagenesis of cdc2+, a cell cycle control gene of the fission yeast Schizosaccharomyces pombe.

Authors:  R Booher; D Beach
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

8.  The decision to enter mitosis.

Authors:  W G Dunphy
Journal:  Trends Cell Biol       Date:  1994-06       Impact factor: 20.808

9.  Direct inhibition of the yeast cyclin-dependent kinase Cdc28-Cln by Far1.

Authors:  M Peter; I Herskowitz
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

10.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  18 in total

1.  Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes.

Authors:  F Liu; C Rothblum-Oviatt; C E Ryan; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1.

Authors:  Marion Peter; Christian Le Peuch; Jean-Claude Labbé; April N Meyer; Daniel J Donoghue; Marcel Dorée
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

3.  Localization and dynamics of Cdc2-cyclin B during meiotic reinitiation in starfish oocytes.

Authors:  Mark Terasaki; Ei-Ichi Okumura; Beth Hinkle; Takeo Kishimoto
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

4.  The Mos pathway regulates cytoplasmic polyadenylation in Xenopus oocytes.

Authors:  C H de Moor; J D Richter
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

5.  Phosphorylation-independent inhibition of Cdc28p by the tyrosine kinase Swe1p in the morphogenesis checkpoint.

Authors:  J N McMillan; R A Sia; E S Bardes; D J Lew
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

6.  Quantitative reconstitution of mitotic CDK1 activation in somatic cell extracts.

Authors:  Richard W Deibler; Marc W Kirschner
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

7.  MAPK inactivation is required for the G2 to M-phase transition of the first mitotic cell cycle.

Authors:  A Abrieu; D Fisher; M N Simon; M Dorée; A Picard
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

8.  The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells.

Authors:  A Blasina; E S Paegle; C H McGowan
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

9.  Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases.

Authors:  H M Ellerby; S J Martin; L M Ellerby; S S Naiem; S Rabizadeh; G S Salvesen; C A Casiano; N R Cashman; D R Green; D E Bredesen
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

10.  Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cells.

Authors:  Xiaodong Zhou; Sung-Hoon Kim; Ling Shen; Hyo-Jung Lee; Changyan Chen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.